These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [Prognostic factors in renal cell carcinoma]. Wen JJ; Zhou XJ Zhonghua Bing Li Xue Za Zhi; 2013 Dec; 42(12):850-3. PubMed ID: 24507112 [No Abstract] [Full Text] [Related]
26. Involvement of bone morphogenetic protein 2 in ossification of renal cell carcinoma. Yamasaki M; Nomura T; Mimata H; Nomura Y J Urol; 2004 Aug; 172(2):475-6. PubMed ID: 15247706 [No Abstract] [Full Text] [Related]
27. Profilin 1 overexpression in renal cell carcinoma. Minamida S; Iwamura M; Kodera Y; Kawashima Y; Ikeda M; Okusa H; Fujita T; Maeda T; Baba S Int J Urol; 2011 Jan; 18(1):63-71. PubMed ID: 21091798 [TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical distribution of CA19-9 in normal and tumor tissues of the kidney. Ohshio G; Ogawa K; Kudo H; Yamabe H; Higuchi K; Nakashima Y; Manabe T; Tobe T Urol Int; 1990; 45(1):1-3. PubMed ID: 2154875 [TBL] [Abstract][Full Text] [Related]
30. Is membranous location of EGFR or EGFRvIII immunostaining associated with good prognosis in renal cell carcinoma? Modjtahedi H; Cunningham MP Br J Cancer; 2005 Nov; 93(11):1316. PubMed ID: 16234813 [No Abstract] [Full Text] [Related]
31. Interleukin-6 produced by renal-cell carcinoma cells and progression of multiple myeloma. Sakai A; Kawano M; Kuramoto A N Engl J Med; 1991 Jun; 324(26):1893-4. PubMed ID: 2041555 [No Abstract] [Full Text] [Related]
32. Influence of growth factors on in vitro invasiveness and type IV collagenolysis of human renal cell carcinoma cells. Otani N; Tsukamoto T; Masumori N; Saiki I; Yoneda J; Kumamoto Y J Urol; 1994 Jan; 151(1):223-6. PubMed ID: 8254819 [TBL] [Abstract][Full Text] [Related]